Greenstein Leonard M. has filed 16 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 44977 shares of CARLSMED, INC. ($CARL) on January 28, 2026.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | CARLSMED, INC. | $CARL | Greenstein Leonard M. | CFO, Treasurer | A | Common Stock | 44977 | $0.00 | 188,346.0000 | 26,592,908 | 31.37% | 0.17% |
| July 22, 2025 | CARLSMED, INC. | $CARL | Greenstein Leonard M. | CFO, Treasurer | A | Stock Options (Right to Buy) | 71429 | $0.00 | 155,102.0000 | 0 | 85.37% | 0.00% |
| April 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 5000 | $14.02 | 26,785.0000 | 24,619,700 | 15.73% | 0.02% |
| March 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 332 | $12.64 | 32,131.0000 | 24,619,700 | 1.02% | 0.00% |
| March 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 346 | $12.15 | 31,785.0000 | 24,619,700 | 1.08% | 0.00% |
| March 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 326 | $12.89 | 32,463.0000 | 24,619,700 | 0.99% | 0.00% |
| March 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 333 | $12.61 | 32,789.0000 | 24,619,700 | 1.01% | 0.00% |
| March 17, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 316 | $13.28 | 33,122.0000 | 24,619,700 | 0.95% | 0.00% |
| March 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 313 | $13.43 | 38,438.0000 | 24,619,700 | 0.81% | 0.00% |
| March 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 5000 | $13.44 | 33,438.0000 | 24,619,700 | 13.01% | 0.02% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | M | Restricted Stock Units | 4462 | $0.00 | 13,388.0000 | 24,619,700 | 25.00% | 0.02% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | M | Common Stock | 4462 | $0.00 | 38,751.0000 | 24,619,700 | 13.01% | 0.02% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | A | Restricted Stock Units | 27160 | $0.00 | 27,160.0000 | 24,619,700 | 9999.99% | 0.11% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | A | Stock Option (right to buy) | 40097 | $0.00 | 40,097.0000 | 24,619,700 | 9999.99% | 0.16% |
| Feb. 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 5000 | $15.12 | 34,289.0000 | 24,619,700 | 12.73% | 0.02% |
| Jan. 19, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Greenstein Leonard M. | Chief Financial Officer | S | Common Stock | 5000 | $14.56 | 39,289.0000 | 24,619,700 | 11.29% | 0.02% |